Digital health companies and investors gathered in Nashville, Tennessee this week for the second annual ViVE conference. Topics among the crowd of 7,500 included “creepiness,” the economy, and concerns about whether ChatGPT was as good as it was built. We have covered five points here.
1. ChatGPT is everything people want to talk about.
The potential for generative AI applications such as ChatGPT and GPT-4 in healthcare was a major topic of conversation. Attendees said he had two thoughts about the potential of ChatGPT in healthcare. This was nicely put together by his Micky Tripathi, Chief of the Office of the National Coordinator of Health Information Technology.
“I think we’re all feeling tremendous excitement, and I want you to feel tremendous fear,” Tripathi said.
Michael Hasselberg, chief digital health officer at the University of Rochester Medical Center in New York, said he believes in the power of generative AI. The ChatGPT developer’s large-scale language AI models with OpenAI are “light years ahead” of what he’s seen on the market from various startups automating healthcare management and revenue cycle processes. .
“It’s very easy to use. I have no formal training as a computer scientist, but I can program in OpenAI,” Hasselberg said. “We can quickly launch an application that can solve a lot of the problems employees have today. [those problems] for me. “
Hasselberg and Steve Kraus, a partner at venture firm Bessemer Venture Partners, say AI models have a lot of potential for automating processes like pre-approval.
However, there was considerable skepticism and even fear of generative AI models. Tripathi says health equity and quality issues can be perpetuated if the algorithm is used improperly. Tom Cassels, CEO of Rock Health Advisory and Consulting, agrees.
“Dangerous [digital health companies] We’re looking at getting into clinical practice and using existing biased medical guidelines and information to introduce big data models,” said Cassels.
